Genetics of Young and early Onset Parkinson's disease from IndiaPublications

The Genetic Drivers of Young and Early Onset Parkinson’s Disease in India

March 22, 2023By 0 comment

This paper was presented as a part of Late breaking abstract at the Asia Oceanic Parkinson’s and Movement Disorders Congress (AOPMC), held at Kolkata, India.  March 16-19, 2023.  The paper address the current findings of genetics of Young Onset Parkinson Disease (YOPD) from Indian cohort.

(LBA-4)

Authors : Shan V Andrews1*†, Prashanth L Kukkle2,3* , Ramesh Menon4*, Thenral S Geetha4 , Vinay Goyal5,6,7, Rukmini Mridula Kandadai8, Hrishikesh Kumar9, Rupam Borgohain8, Adreesh Mukherjee10, Pettarusp M Wadia11, Ravi Yadav12, Soaham Desai13, Niraj Kumar14, Deepika Joshi15, Sakthivel Murugan4, Atanu Biswas10 , Pramod K Pal12 , Merina Oliver4, Sandhya Nair4, Anbu Kayalvizhi4, Udita Mahadevia4, Susinder Sundaram4, Manjari Deshmukh4, Akshi Bassi4, Charugulla Sandeep4, Nitin Mandloi4, Uday Muthane16, Shymal K Das10, Andrew S Peterson4, Thomas Sandmann1, Ravi Gupta4, Vedam L Ramprasad4, Parkinson Research Alliance of India (PRAI)

1Denali Therapeutics, South San Francisco, CA, 2Parkinson’s Disease and Movement Disorders Clinic, Bangalore, India, 3Manipal Hosp., Bangalore, India, 4MedGenome Labs Pvt Ltd, Bangalore, India, 5All India Inst. of Med. Sci.

(AIIMS), New Delhi, India, 6Medanta Hosp., New Delhi, India, 7Medanta, The Medicity, Gurgaon, India, 8Nizams Inst. of Med. Sci. (NIMS), Hyderabad, India, 9Inst. of NeuroSci.s Kolkata, Kolkata, India, 10Bangur Inst. of NeuroSci.s and Inst. of Post Graduate Med. Ed. and Res. (IPGME&R), Kolkata, India, 11Jaslok Hosp. and Res. Ctr., Mumbai, India, 12Natl. Inst. of Mental Hlth.and NeuroSci.s (NIMHANS), Bangalore, India, 13Shree Krishna Hosp. and Pramukhaswami Med. Coll., Bhaikaka Univ., Karamsad, India, 14All India Inst. of Med. Sci., Rishikesh, India, 15Dept. of Neurology, Inst. of Med. Sci., Banaras Hindu Univ., Varanasi, India, 16Parkinson and Ageing Res. Fndn., Bangalore, India

Genetics of Young and early Onset Parkinson's disease from India
READ MORE
Publications

Genetics Of Parkinson’s in India – Young Onset Parkinson’s Disease (GOPI-YOPD) : Genetics of Juvenile, Young, and Early Onset Parkinson’s Disease

March 9, 2023By 9 Comments

Prashanth LK, Vinay Goyal, Thenral S Geetha, Ramesh Menon, Rukmini Mridula Kandadai, Hrishikesh Kumar, Rupam Borgohain, Adreesh Mukherjee, Pettarusp M Wadia, Ravi Yadav, Soaham Desai, Niraj Kumar, Ravi Gupta, Sakthivel Murugan, Atanu Biswas, Pramod K Pal, Merina Oliver, Susinder Sundaram, Manjari Deshmukh, Akshi Bassi, Charugulla Sandeep, Nitin Mandloi, Uday Muthane,  Shymal K Das, Somasekar Seshagiri, Vedam L Ramprasad, – Parkinson Research Alliance of India (PRAI)

Presented as abstract at the International Parkinsons and Movement Disorders Society Conference held in September 2022 at Madrid, Spain.

Background: 

To determine the genetic and demographic patterns of juvenile-onset (JOPD, <20 years), young-onset (YOPD, 20-40 years), and early onset (EOPD, 40-50 years) Parkinson’s disease (PD) in India.

Methodology: 

GOPI-YOPD is a prospective multicenter, collaborative study to analyze clinical and genetic patterns of JOPD, YOPD, and EOPD1.  Genetic data of 662 samples ( Whole Genome Genotyping = 572, Whole Exome Sequencing =572; Whole Genome Sequencing=90) were analyzed. Rare and known pathogenic and risk SNVs/InDels and CNVs in primary PD genes (11), risk PD genes (12), and additional PD genes (40) were analyzed.

Results: 

Clinical cohort: A total of 668 subjects (M:F 455:213) were recruited with a mean age at onset of 38.7 ± 8.1 years. The mean duration of symptoms at the time of study was 8 ± 6 years. Fifteen percent had a family history of PD and 13% had consanguinity. JOPD had the highest consanguinity rate (53%). YOPD and JOPD cases had a higher prevalence of consanguinity, dystonia, and gait and balance issues compared to those with EOPD. In relation to nonmotor symptoms, panic attacks and depression were more common in YOPD and sleep-related issues more common in EOPD subjects. Overall, dyskinesias were documented in 32.8%. YOPD subjects had a higher frequency of dyskinesia than EOPD subjects (39.9% vs. 25.5%), but they were first noted later in the disease course (5.7 vs. 4.4 years).

Genetic findings:  Among PD cases we prioritized 617 variants in 402 samples. Pathogenic and likely pathogenic variants were identified in 5.1% and 4.7% PD cases respectively. In a large number of PD cases (51%) variants of uncertain significance (VUS) were identified. Risk variants were identified in another 5.9% of the PD cases. The most frequent genes with pathogenic variants included PRKN (n=36, 5.4%), PLA2G6 (n=12, 1.8%), PINK1(n=8, 1.2%), CHCHD2 (n=4, 0.6%),VPS13C(n=4), PANK2 (n=3), SPG11 (n=3), SYNJ1 (n=3), ATP13A2 (n=2), FBX07 (n=1), MAPT (n=1), PRRT2 (n=1), WDR45 (n=1), GCH1 (n=1).  Many risk variants/VUS were identified in GBA (n= 59 / 8.9%) and LRRK2 (n=27 /4.1%). In several PD cases we found homozygous deletion in the PRKN gene (n=20 / 3%). Overall, the diagnostic yield is found to be high in JOPD (43.7%), followed by YOPD (10.9%) and EOPD (4%). We also generated PD polygenic risk scores (PRS) using SARGAM genotyping array data. PRS revealed that the PD cases with no prioritized pathogenic/likely pathogenic variants have significantly (p-value < 0.001) higher PD PRS as compared to control population and PD with prioritized pathogenic/likely pathogenic variants.

Conclusion: 

This large cohort shows differing genetic patterns in JOPD, YOPD, and EOPD cases. PRKN gene is the commonest pathogenetic variant and has large pathogenetic deletions. In addition to pathogenic mutations, a high percentage of VUS indicates untapped genetic understanding. The PRS carries diagnostic utility for possible regular use.

Reference:

  1. Kukkle PL, Goyal V, Geetha TS, Mridula KR, Kumar H, Borgohain R, Mukherjee A, Wadia PM, Yadav R, Desai S, Kumar N, Gupta R, Biswas A, Pal PK, Muthane U, Das SK, Quinn N, Ramprasad VL; Parkinson Research Alliance of India (PRAI). Clinical Study of 668 Indian Subjects with Juvenile, Young, and Early Onset Parkinson’s Disease. Can J Neurol Sci. 2022 Jan;49(1):93-101. doi: 10.1017/cjn.2021.40.
READ MORE